Indivior PLC [INDV] vs Zoetis [ZTS] Detailed Stock Comparison
Indivior PLC
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Indivior PLC wins in 7 metrics, Zoetis wins in 11 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Indivior PLC | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.99 | 25.36 | Zoetis |
| Price-to-Book Ratio | N/A | 13.14 | N/A |
| Debt-to-Equity Ratio | -1.42 | 137.01 | Indivior PLC |
| PEG Ratio | 21.94 | 23.24 | Indivior PLC |
| EV/EBITDA | 8.29 | 17.91 | Indivior PLC |
| Profit Margin (TTM) | 4.52% | 27.83% | Zoetis |
| Operating Margin (TTM) | 23.51% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | 23.51% | 40.20% | Zoetis |
| Return on Equity | -0.57% | 52.77% | Zoetis |
| Return on Assets (TTM) | 13.14% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $5.00M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | 95.53% | -16.11% | Indivior PLC |
| Price-to-Sales Ratio (TTM) | 2.50 | 6.96 | Indivior PLC |
| Enterprise Value | $2.79B | $70.67B | Zoetis |
| EV/Revenue Ratio | 2.38 | 7.53 | Indivior PLC |
| Gross Profit Margin (TTM) | 82.78% | 73.62% | Indivior PLC |
| Revenue per Share (TTM) | $9 | $21 | Zoetis |
| Earnings per Share (Diluted) | $0.81 | $5.81 | Zoetis |
| Beta (Stock Volatility) | 0.96 | 0.88 | Zoetis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Indivior PLC vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Indivior PLC | 1.12% | 3.80% | 54.17% | 113.02% | 184.62% | 92.40% |
| Zoetis | 1.51% | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Indivior PLC | 95.53% | 550.00% | 1,471.90% | 617.91% | 964.16% | 964.16% |
| Zoetis | -16.11% | -9.09% | -2.69% | 242.31% | 396.97% | 396.97% |
Performance & Financial Health Analysis: Indivior PLC vs Zoetis
| Metric | INDV | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.93B | $65.30B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 2,382,039 | 4,111,510 |
| 90 Day Avg. Volume | 3,518,626 | 3,459,870 |
| Last Close | $24.32 | $167.10 |
| 52 Week Range | $7.33 - $24.64 | $139.70 - $200.33 |
| % from 52W High | -1.30% | -16.59% |
| All-Time High | $26.50 (Jun 12, 2023) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -8.23% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.04% |
| Quarterly Earnings Growth | 0.01% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.28% |
| Operating Margin (TTM) | 0.24% | 0.40% |
| Return on Equity (TTM) | -0.01% | 0.53% |
| Debt to Equity (MRQ) | -1.42 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-2.06 | $11.21 |
| Cash per Share (MRQ) | $4.09 | $3.28 |
| Operating Cash Flow (TTM) | $205.00M | $2.93B |
| Levered Free Cash Flow (TTM) | $255.25M | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | N/A | $1.86 |
Valuation & Enterprise Metrics Analysis: Indivior PLC vs Zoetis
| Metric | INDV | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.99 | 25.36 |
| Forward P/E | 21.94 | 23.24 |
| PEG Ratio | 21.94 | 23.24 |
| Price to Sales (TTM) | 2.50 | 6.96 |
| Price to Book (MRQ) | N/A | 13.14 |
| Market Capitalization | ||
| Market Capitalization | $2.93B | $65.30B |
| Enterprise Value | $2.79B | $70.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.38 | 7.53 |
| Enterprise to EBITDA | 8.29 | 17.91 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 0.88 |
| Book Value per Share (MRQ) | $-2.06 | $11.21 |
Financial Statements Comparison: Indivior PLC vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INDV | ZTS |
|---|---|---|
| Revenue/Sales | $302.00M | $2.22B |
| Cost of Goods Sold | $52.00M | $622.00M |
| Gross Profit | $250.00M | $1.60B |
| Research & Development | $21.00M | $157.00M |
| Operating Income (EBIT) | $71.00M | $846.00M |
| EBITDA | $82.00M | $991.00M |
| Pre-Tax Income | $62.00M | $810.00M |
| Income Tax | $44.00M | $179.00M |
| Net Income (Profit) | $18.00M | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INDV | ZTS |
|---|---|---|
| Cash & Equivalents | $372.00M | $1.72B |
| Total Current Assets | $883.00M | $5.88B |
| Total Current Liabilities | $1.01B | $3.39B |
| Long-Term Debt | $341.00M | $5.40B |
| Total Shareholders Equity | $-286.00M | $4.66B |
| Retained Earnings | $-406.00M | $12.38B |
| Property, Plant & Equipment | $141.00M | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INDV | ZTS |
|---|---|---|
| Operating Cash Flow | $72.00M | $567.00M |
| Capital Expenditures | $-5.00M | N/A |
| Free Cash Flow | $70.00M | $438.00M |
| Debt Repayment | $-4.00M | N/A |
| Common Stock Repurchase | $-11.00M | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | INDV | ZTS |
|---|---|---|
| Shares Short | 7.12M | 7.85M |
| Short Ratio | 2.08 | 2.67 |
| Short % of Float | 0.06% | 0.02% |
| Average Daily Volume (10 Day) | 2,382,039 | 4,111,510 |
| Average Daily Volume (90 Day) | 3,518,626 | 3,459,870 |
| Shares Outstanding | 124.90M | 448.47M |
| Float Shares | 89.80M | 442.37M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.95% | 0.98% |
Dividend Analysis & Yield Comparison: Indivior PLC vs Zoetis
| Metric | INDV | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | N/A | $1.63 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $4.90 |
| Ex-Dividend Date | N/A | Apr 21, 2025 |